Jeremy Grantham's position in Pfizer is currently worth $68.3 Million. That's 0.29% of their equity portfolio (57th largest holding). The first Pfizer trade was made in Q1 2013. Since then Jeremy Grantham bought shares eighteen more times and sold shares on 25 occasions. The investor's estimated purchase price is $75.7 Million, resulting in a loss of 9.7%.